Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ——55.3 K263.21 K248.86 K — Research & development ————— — Operating income -215.75 K-177.73 K-225.28 K-398.89 K-432.9 K -1.23 M Non-Operating Income, Total 896.6 K900.94 K911.97 K856.09 K786.31 K 3.46 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 896.6 K900.94 K911.97 K856.09 K786.31 K 3.46 M Unusual income/expense ————— — Pretax income 680.85 K723.21 K686.69 K457.2 K353.41 K 2.22 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 680.85 K723.21 K686.69 K457.2 K353.41 K 2.22 M Discontinued operations ————— — Net income 680.85 K723.21 K686.69 K457.2 K353.41 K 2.22 M Dilution adjustment ————786.31 K — Preferred dividends ————786.31 K — Diluted net income available to common stockholders 680.85 K723.21 K686.69 K457.2 K353.41 K 2.22 M Basic earnings per share (Basic EPS) 0.180.210.180.120.09 0.6 Diluted earnings per share (Diluted EPS) 0.180.210.180.120.09 0.6 Average basic shares outstanding 19.65 M19.65 M19.65 M19.65 M19.65 M — Diluted shares outstanding 11.03 M11.03 M19.65 M19.65 M19.65 M — EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —